Samsara BioCapital, L.P.
Insider transactions at 3 companies
This page shows all SEC Form 4 filings attributed to Samsara BioCapital, L.P.. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| MLYS | Purchase | 600,000 | $13.50 | $8,100,000 | Mar 13, 2025 | |
| 0001966494 | Purchase | 294,000 | $17.00 | $4,998,000 | May 30, 2024 | |
| VTVT | Other | 58,836 | — | — | Mar 5, 2024 | |
| MLYS | Purchase | 555,555 | $13.50 | $7,499,993 | Feb 12, 2024 | |
| LENZ | Purchase | 22,329 | $10.19 | $227,533 | Dec 15, 2021 | |
| LENZ | Purchase | 45,400 | $13.22 | $600,188 | Oct 15, 2021 |